Current Report Filing (8-k)
August 04 2016 - 4:42PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington,
D.C. 20549
_________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR
15(d) of the Securities Exchange Act of 1934
Date of Report (Date of
earliest event reported): August 1, 2016
THE CLOROX
COMPANY
(Exact name of registrant
as specified in its charter)
_________________
Delaware
|
1-07151
|
31-0595760
|
(State or other jurisdiction of
|
(Commission File Number)
|
(I.R.S. Employer
|
incorporation)
|
|
Identification No.)
|
1221 Broadway, Oakland,
California
94612-1888
(Address of principal executive offices) (Zip
code)
(510) 271-7000
(Registrant's telephone
number, including area code)
Not applicable
(Former name or former
address, if changed since last report)
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing
obligation of the registrant under any of the following provisions:
[ ] Written
communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))
Item
5.02
|
|
Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
|
On August 4, 2016, the Board
of Directors (the Board) of The Clorox Company (the Company) announced
several actions taken on August 1, 2016, which are each effective August 15,
2016.
The Board appointed Benno
Dorer, Chief Executive Officer of the Company, as Chairman of the Board. The
Board also appointed Pamela Thomas-Graham as independent Lead Director of the
Board.
The Board also elected Allan
D. David Mackay to the Board. In addition, the Board appointed Mr. Mackay to
the Boards Management Development and Compensation Committee. Mr. Mackay will
be entitled to compensation in accordance with the Companys standard
non-employee director compensation program.
A press release announcing the
appointments of Mr. Dorer and Ms. Thomas-Graham and the election of Mr. Mackay
is filed as Exhibit 99.1 hereto and is incorporated herein in its entirety.
Item 9.01 Financial
Statements and Exhibits
(d) Exhibits
Exhibit
|
|
Description
|
99.1
|
|
Press Release
dated August 4, 2016, of The Clorox Company
|
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
THE CLOROX COMPANY
|
|
|
|
|
Date: August 4,
2016
|
|
By:
|
/s/ Laura Stein
|
|
|
|
Executive Vice
President General Counsel
|
|
|
|
and Corporate
Affairs
|
THE CLOROX
COMPANY
FORM 8-K
INDEX TO EXHIBITS
Exhibit
|
|
Description
|
99.1
|
|
Press Release
dated August 4, 2016, of The Clorox Company
|
Clorox (NYSE:CLX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Clorox (NYSE:CLX)
Historical Stock Chart
From Apr 2023 to Apr 2024